Quest Diagnostics Incorporated
DGX
$190.18
$0.370.20%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.86% | 0.00% | -13.12% | 28.18% | -0.90% |
| Total Depreciation and Amortization | 1.38% | 2.11% | -0.70% | 2.14% | 3.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 709.09% | -92.90% | 142.19% | 45.45% | -40.54% |
| Change in Net Operating Assets | -428.13% | 204.76% | -61.82% | 161.11% | -372.73% |
| Cash from Operations | -40.22% | -17.41% | 3.49% | 73.25% | -32.33% |
| Capital Expenditure | 27.85% | -9.72% | -33.33% | 7.69% | 4.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 24.00% | -47.06% | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 173.91% | -2,400.00% | -50.00% | -50.00% |
| Cash from Investing | 20.42% | 4.98% | -62.10% | -7.83% | 77.09% |
| Total Debt Issued | -- | -100.00% | -94.59% | -13.95% | -- |
| Total Debt Repaid | 0.00% | 90.00% | 97.51% | 33.17% | -59,900.00% |
| Issuance of Common Stock | 261.11% | -5.26% | 46.15% | -55.17% | 38.10% |
| Repurchase of Common Stock | 87.71% | -98.03% | -- | 100.00% | 72.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.22% | -1.12% | 1.11% | -7.14% | 0.00% |
| Other Financing Activities | -204.60% | 448.00% | -- | 100.00% | -275.56% |
| Cash from Financing | 47.04% | -16.19% | 15.70% | 47.77% | -230.00% |
| Foreign Exchange rate Adjustments | -200.00% | 150.00% | -150.00% | 300.00% | 114.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.00% | -110.62% | -13.74% | 136.29% | -67.91% |